|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/7048 | |
| A61K 31/19 | |||
| A61K 31/56 | |||
| A61K 36/24 | |||
| A61K 9/20 | |||
| A61K 9/48 | |||
| A61K 45/06 | |||
| A61P 31/12 | |||
| A61P 31/14 |
| (11) | Number of the document | 3512524 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17851523.5 |
| Date of filing the European patent application | 2017-09-14 | |
| (97) | Date of publication of the European application | 2019-07-24 |
| (45) | Date of publication and mention of the grant of the patent | 2021-04-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2017/051553 |
| Date | 2017-09-14 |
| (87) | Number | WO 2018/053123 |
| Date | 2018-03-22 |
| (30) | Number | Date | Country code |
| 201662394504 P | 2016-09-14 | US |
| (72) |
NEWMAN, Robert, A., US
ADDINGTON, Otis, C., US
|
| (73) |
Phoenix Biotechnology, Inc.,
8626 Tesoro Dr., San Antonio, TX 78217,
US
|
| (54) | METHOD AND COMPOSITIONS FOR TREATING VIRAL INFECTION |
| METHOD AND COMPOSITIONS FOR TREATING VIRAL INFECTION |